Studies indicate that comfort air mattress ingested oral cyanocobalamin tablets are ineffective in the treatment of allergic disease, air perhaps mattress because once ingested, they are comfort air mattress directly metabolized in the liver. when b12 is delivered via injection or lozenge it passes throughout the bloodstream before arriving at the liver. it is during this first pass in its native form that it is believed to exert its therapeutic effect. clinical air research: "the world health organization (who) recognizes allergic rhinitis (hay fever), sinusitis, asthma,...conjunctivitis, urticaria, eczema, dermatitis (contact and atopic)...allergic and migraine headache...as diseases in which ige-mediated allergy may be involved."1 in 1988, asthma and allergic rhinitis subjects were treated with b12. total ige, specific ige and pulmonary lung functions were taken at days 45, 150 and 180 from baseline. eight of the 9 subjects had reduced ige. 2 in 1989 open label studies at two sites in riverside county, ca in 1989. sixteen of the 17 mattress subjects comfort had lowered ige levels from day 0 to day 30.3

in 1992 in el paso, tx a randomized, double-blind, placebo controlled study of subjects (n=130) with allergic rhinitis in 1992-1993 was conducted. the average ige level of the placebo treated subjects remained air essentially flat, while the average ige level for active treated subjects was reduced significantly from baseline to day 30.7 in 1993 in el paso, tx, valid subjects (n=66) returned a second set of symptom diaries which they had completed for days 365 to 395 (the same period, one year after the first set mattress of symptom diaries). the active group had mean symptom scores showing statistically significant decreases from 1992 to 1993. the placebo group had increased symptoms in 1993. (the relevant pollen counts at the study site in comfort 1993 were much higher than in 1992, leading to expectation of higher symptoms.)7

in 1990 study in san diego, ca the 5 active subjects with allergic rhinitis air had a lowered total serum ige from day 0 to day 90 while 4 placebo subjects, (2 with allergic rhinitis, 1 with asthma and 1 with both), had flat or increased ige levels.4 in a randomized, double-blind, placebo controlled study of symptoms and serum ige levels in san diego, ca in mid-1991, mattress subjects had comfort allergic rhinitis and/or asthma. serum was drawn at day 0 and day 30. seven of the 10 active treated subjects had a reduction in total serum ige levels. in 10 placebo treated subjects, air 5 had levels of total serum ige that stayed the same (plus or minus 5%), 3 decreased and 2 increased.5 mattress statistical analysis of the open-label study as well as the double-blind randomized placebo controlled study have shown a significant effect of vitamin b12 in lowering serum ige concentrations.

©2003 www.mattress-air-beds.com All rights reserved.